Showing 101 - 120 results of 100,826 for search '(( 5 ht decrease ) OR ( 5 ((non decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.50s Refine Results
  1. 101
  2. 102
  3. 103
  4. 104
  5. 105

    U87MG glioma cells transduced with gal-3 shRNA demonstrate decreased tumor size and growth. by Rafael Yamashita Ikemori (698128)

    Published 2014
    “…The inoculation of U87MG gal-3 shRNA cells in the flank of nuce mice (n = 5) demonstrated a decrease in tumor size and growth compared to the U87MG scramble shRNA (n = 6). …”
  6. 106
  7. 107
  8. 108
  9. 109

    <i>Ext1</i> mutant lungs exhibit a decrease in SHH-FGF10 signaling. by Hua He (120374)

    Published 2017
    “…<p>(A) qPCR analysis of key components of FGF signaling pathway in lungs from E14.5. …”
  10. 110
  11. 111

    Participant characteristics (non-weighted). by Ruth Barclay (8428956)

    Published 2024
    “…Multivariate logistic regression models were developed for community ambulation. Mean age was 68 (SE 0.5) years (45% female). In the final community ambulation model (n = 855), factors associated with being less likely to ‘walk outdoors sometimes or often’ included difficulty or being unable to walk 2–3 blocks (decreased endurance) vs. no difficulty. …”
  12. 112
  13. 113
  14. 114
  15. 115
  16. 116

    The decrease or inhibition of Hsp90 induced REST degradation. by Raúl Orozco-Díaz (7067624)

    Published 2019
    “…<p>(A) Effect of Hsp90α ASO on cell viability. Differentiated SH-SY5Y cells were transfected with different concentrations of Hsp90α ASO. …”
  17. 117
  18. 118

    The MMP was decreased by incubation with CytoD or LatB. by Dong-Hee Yang (566631)

    Published 2014
    “…An MMP collapse was detected as a decrease in the percentage of cells with high red fluorescence intensity. …”
  19. 119

    The MMP was decreased by incubation with CytoD or LatB. by Dong-Hee Yang (566631)

    Published 2014
    “…An MMP collapse was detected as a decrease in the percentage of cells with high red fluorescence intensity. …”
  20. 120

    The NK1-receptor antagonist ezlopitant significantly decreases voluntary intake of non-caloric saccharin solution. by Pia Steensland (362091)

    Published 2013
    “…<p>Ezlopitant (5 and 10 mg/kg) significantly decreased consumption of the non-caloric 0.2% saccharin solution compared to vehicle. …”